86 results
Page 2 of 5
F-3
b5i0 913zb
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
vtmwhe25 x6rnzrdnf
17 Feb 22
Shelf registration (foreign)
4:14pm
F-3
EX-5.1
xoytdkf doz
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
EX-99.3
r8x6 d9yv
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
424B7
0h33nsjl652xwl q3z
23 Nov 21
Prospectus with selling stockholder info
4:06pm
F-3
d28ou vlvmt786ks
10 Nov 21
Shelf registration (foreign)
5:23pm
F-3
EX-5.1
20kx86ixkb7 x0b
10 Nov 21
Shelf registration (foreign)
5:23pm
6-K/A
EX-99.1
85ukv4 nh5g
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.2
n8eag
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K/A
EX-99.5
tsax u3d6ojm4tb53
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.5
jlajv1
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
8kcweqmmo3k3mf
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
u6qbpd4sg6dz1r p1qai
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.1
revpduv3e3hnexorjym
22 Apr 21
ObsEva Annual General Meeting 2021
6:31am
6-K
EX-5.1
635 o27346le
5 Mar 21
Current report (foreign)
8:15am
6-K
EX-1.1
4puyb07o9ph83yi
5 Mar 21
Current report (foreign)
8:15am
424B5
eq7cw2
5 Mar 21
Prospectus supplement for primary offering
7:55am